{
  "actions": [
    {
      "acted_at": "2019-10-08",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2019-10-08",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2019-10-08",
      "action_code": "H11100",
      "committees": [
        "HSWM"
      ],
      "references": [],
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2019-10-08",
      "action_code": "",
      "committees": [
        "HSWM"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    },
    {
      "acted_at": "2019-10-09",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    },
    {
      "acted_at": "2019-10-18",
      "action_code": "B00100",
      "references": [
        {
          "reference": "CR H8232",
          "type": null
        }
      ],
      "text": "Sponsor introductory remarks on measure.",
      "type": "action"
    }
  ],
  "amendments": [],
  "bill_id": "hr4629-116",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Ways and Means",
      "committee_id": "HSWM"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Ways and Means",
      "committee_id": "HSWM",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "02"
    }
  ],
  "congress": "116",
  "cosponsors": [
    {
      "bioguide_id": "G000563",
      "district": "7",
      "name": "Gibbs, Bob",
      "original_cosponsor": true,
      "sponsored_at": "2019-10-08",
      "state": "OH",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2019-10-08",
  "number": "4629",
  "official_title": "To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to add a new set of measures to the 5-star rating system under the Medicare Advantage program in order to encourage increased access to biosimilar biological products.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr3-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    },
    {
      "bill_id": "s2543-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    },
    {
      "bill_id": "s4199-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": "Star Rating for Biosimilars Act",
  "sponsor": {
    "bioguide_id": "T000469",
    "district": "20",
    "name": "Tonko, Paul",
    "state": "NY",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2019-10-08",
  "subjects": [
    "Health",
    "Health care costs and insurance",
    "Health care coverage and access",
    "Health care quality",
    "Health programs administration and funding",
    "Medicare",
    "Performance measurement",
    "Prescription drugs"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2019-10-08",
    "date": "2020-11-16T15:37:55Z",
    "text": "Star Rating for Biosimilars Act\n\nThis bill requires the Centers for Medicare & Medicaid Services (CMS) to establish quality measures regarding biosimilar biological products under the five-star performance rating system for Medicare Advantage plans. The measures must assess the level of access that plans provide to covered biosimilars, including with respect to formularies, cost-sharing, and utilization management.\n\nThe CMS must also incorporate such measures into similar rating systems for plans under the Medicare prescription drug benefit."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Star Rating for Biosimilars Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to add a new set of measures to the 5-star rating system under the Medicare Advantage program in order to encourage increased access to biosimilar biological products.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Star Rating for Biosimilars Act",
      "type": "short"
    }
  ],
  "updated_at": "2022-11-01T13:49:43Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr4629.xml"
}